Moneycontrol PRO


Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10%

According to average of estimates of analysts polled by CNBC-TV18, revenue during the quarter may increase 11.6 percent year-on-year to Rs 7,905.3 crore, driven by Sun's authorised generic (AG) launches of Daichi Sankyo drugs in US.

first published: Feb 13, 2017 05:47 pm


Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows